FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Avkare Dutasteride Capsules Recall

Dutasteride Capsules, 0

AVKARE Inc. · Pulaski, TN

Risk level
Class II
Reported by FDA
Jan 22, 2020
Recall ID
D-0661-2020
Check your lot numberHow we source this data

Summary

Avkare recalled Dutasteride Capsules starting Jan 7, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0661-2020 on Jan 22, 2020. Reason: Failed Impurities/Degradation Specifications: High out of specification results for related compounds. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: High out of specification results for related compounds.

Product description

Dutasteride Capsules, 0.5 mg, 30 Capsules (6 X 5) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-282-13.

Lot numbers, UPCs & expiration codes

Lots: 25246, Exp. 02/2021; 24532, Exp. 10/2020; 23647, Exp. 06/2020

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0661-2020
Classification
Class II
Status
Terminated
Recall initiated
Jan 7, 2020
FDA report date
Jan 22, 2020
Quantity
3,989 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
AVKARE Inc.

Original FDA data

Every field from FDA enforcement report D-0661-2020, exactly as published.

Show all FDA fields
City
Pulaski
State
TN
Status
Terminated
Country
United States
Event ID
84677
Address
615 N 1st St
Code information
Lots: 25246, Exp. 02/2021; 24532, Exp. 10/2020; 23647, Exp. 06/2020
Postal code
38478-2403
Report date
Jan 22, 2020
Product type
Drugs
Recall number
D-0661-2020
Classification
Class II
Recalling firm
AVKARE Inc.
Product quantity
3,989 cartons
Termination date
Jul 14, 2021
Reason for recall
Failed Impurities/Degradation Specifications: High out of specification results for related compounds.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dutasteride Capsules, 0.5 mg, 30 Capsules (6 X 5) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-282-13.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Jan 7, 2020
Initial firm notification
Letter
Center classification date
Jan 13, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0661-2020, published Jan 22, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls